We are transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our patient care program
Outdoor plans for the holiday? Remember the sunscreen! The number of skin cancer cases in the state of Kansas is growing at an alarming rate. Yet, skin cancer is one of the most preventable of cancers. Protect your skin and your kids' skin with sunscreen. https://t.co/jWGfkksy8g
“Cancer is evil.” That simple motivation drives Dr. Roy Jensen, of @KUCancerCenter to continue the fight against cancer. Through shared expertise, AACI members are advancing progress in areas like cellular therapies and immunotherapy. #BetterTogether#AACIBetterTogether
Why are more young adults being diagnosed with cancer?
Read the cover story from the latest edition of Kansas Medicine + Science: https://t.co/FuXXznSNsI
“One of the reasons we wanted to give specifically to the GMP laboratory is because right now, CAR T cells are being shipped out and sent back, and that’s time some of these patients don’t have.” - Eric Ryan, Cinelli Family Foundation
The state-of-the-art Good Manufacturing Practice (GMP) laboratory in our new cancer center building will deliver these life-saving therapies to our patients even faster.
Read more about the lab and one patient's "Hail Mary" procedure. → https://t.co/zA1ZedfR5E
@KUEndowment
Future leaders in science and medicine stayed busy this summer!
Congratulations to the high school, undergraduate and graduate students who presented their summer research projects last week. Dozens of young learners presented 33 posters after engaging in hands-on learning through programs offered by the cancer center and @KUMedCenter.
Congratulations to Julia White, MD, FASCO, on being named an @ASCO Fellow! This prestigious honor recognizes her leadership in breast cancer research, clinical care and shaping national treatment guidelines that improve patient outcomes. Well deserved! @KURadonc
https://t.co/J6FcUizqPM
14 undergraduate, graduate and professional students are spending their summer with @KURadonc physicians and researchers.
The Radiation Oncology Summer Internship Program offers motivated students the opportunity to gain hands-on experience in clinical research, explore the field of radiation oncology and learn from faculty mentors engaged in academic medicine.
If you know a curious, analytical problem solver interested in next Summer's program, keep an eye out for registration details this fall.
Congratulations to Sufi Thomas, PhD, on being named the Frank B. Tyler Endowed Professor in Cancer Research. From advancing our understanding of the tumor microenvironment to improving survivorship through innovative research, her work is making a lasting impact. https://t.co/R85J8QnJWx
How far we've come!
On the newest episode of Bench to Bedside, Dr. Roy Jensen sat down with his predecessor, Dr. William Jewell, to reflect on the early days of The University of Kansas Cancer Center and the changes made to earn NCI designation.
Listen on your preferred podcast platform or our website → https://t.co/Iqn90NjsTi
What does science say about the link between obesity and cancer?
Kristy Brown, PhD, co-authored a comprehensive review of scientific literature explaining the relationships obesity has with your immune system, gut microbiome, DNA and more. Read her comments on the article published in @JAMA_current → https://t.co/eWVeDESuUx
I wonder what the HOPE on Wheels odometer will read this time next year. Check out its upcoming events across Kansas and Western Missouri: https://t.co/wyXlj5Uzvk
Thanks @AAMCtoday for the highlight!
The rural health gap is real, and it shows up in cancer outcomes. @KUcancercenter's mobile screening unit meets patients where they are, bringing free cancer screenings directly to communities across Kansas and western Missouri. https://t.co/zqBLnlXqzR
Our clinical trial leaders gathered with colleagues from around the country this week at the 18th annual @AACI_Cancer Clinical Research Innovation Meeting.
Erin Winters joined a panel on multidisciplinary collaboration, explaining how the cancer center evolved cellular therapy from a hematologic malignancy program into an institution-wide platform.
Thank you Erin and our clinical trial leaders for sharing your insights and fostering collaboration with other cancer centers.
#AACICRI #CRI2026
At a June 10 event, the Kansas Masonic Foundation honored Roy Jensen, MD, and announced a Distinguished Masonic Professorship in his name.
His leadership helped KU Cancer Center earn NCI comprehensive designation and expand access to care. Read more: https://t.co/RuyNd4WzJe
What if we could stop cancer before it starts? Join host Dr. Roy Jensen on the Bench to Bedside podcast with guest Dr. Lauren Nye as they explore innovative strategies in cancer prevention clinical trials. Tune in today: https://t.co/ggYGRAtQ1R
Recently, the Royals and @KUcancercenter teamed up to host the first annual Royal Resilience luncheon. Five men's cancer survivors, with their caregivers and physicians, were celebrated and honored at Kauffman Stadium. Participants heard from Royals alumni Les Norman and Jeff Montgomery, went on a VIP stadium tour, and played catch on the field with Kyle Isbel. It was a great day!
University of Kansas Medical Center' Ron Chen, MD, MPH, FASCO, FASTRO, Chair, Radiation Oncology, participated in Royal Resilience: Men's Cancer Survivorship Luncheon.
@RonaldChenMD@KUcancercenter@KUMedicine@Royals
Research fuels progress.💙
Hear from Dr. Akhavan of @KUcancercenter as he shares how research funding from Head for the Cure is helping advance discoveries in brain tumor treatment and care.
Learn more and help bring hope to the brain tumor community:
https://t.co/LQEbPU4hUg
A new "Triple Threat" CAR T-cell therapy developed at KU Cancer Center is designed to attack three cancer targets at once, potentially overcoming a major challenge in treating blood cancers.
Ramesh Balusu, PhD, scientific director of the Midwest Stem Cell Therapy Center, recently sat down with @SocietyofHemOnc to discuss early results from a phase 1 clinical trial and the benefits of engineering T-cells on-site.
https://t.co/XGGeNHPhdF
On the latest episode of the Bench to Bedside podcast, Dr. Tara Lin and Dr. Jesus Gonzalez Lugo share an update on #MyeloMATCH, a first-of-its-kind national clinical trial designed to bring precision medicine to patients with #AML. Tune in today: https://t.co/ggYGRAtQ1R